<DOC>
	<DOCNO>NCT02009449</DOCNO>
	<brief_summary>This first-in-human , open-label , dose escalation study evaluate safety tolerability AM0010 patient advance solid tumor , dose daily subcutaneously monotherapy combination chemotherapy immunotherapy .</brief_summary>
	<brief_title>A Phase 1 Study AM0010 Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Pembrolizumab</mesh_term>
	<mesh_term>Nivolumab</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Part A Escalation Cohorts : Histologically cytologically confirm advanced malignant solid tumor , limited melanoma , castrate resistant prostate cancer ( CRPC ) , ovarian cancer ( OVCA ) , renal cell carcinoma , colorectal carcinoma ( CRC ) , pancreatic carcinoma nonsmall cell lung carcinoma ( NSCLC ) refractory , intolerant , standard therapy available patient refuse exist therapy Part A Expansion Cohorts , Part B C Escalation Expansion Cohorts : Tumors histological diagnosis tissue origin may enrol Patients must fail prior standard curative chemotherapy disease , refuse exist therapy OR propose chemotherapy regimen AM0010 add represent acceptable standard treatment disease . Measurable evaluable disease accord irRC bone metastatic disease evaluable Prostate Cancer Working Group 2 criterion ( PCWG2 ) castrationresistant prostate cancer ( CRPC ) At least 18 year age Performance Status 0 1 Adequate organ function Hematologic malignancy Pregnant lactate Present history neurological disorder Multiple Sclerosis Guillain Barre inflammatory central nervous system/peripheral nervous system ( CNS/PNS ) disorder Myocardial infarction within last 6 month Unstable angina , unstable cardiac arrhythmia require medication Surgery within last 28 day Systemic fungal , bacterial , viral , infection History bleeding diathesis within last 6 month Positive human immunodeficiency virus ( HIV ) , hepatitis C , hepatitis B</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Phase 1/Phase 1b</keyword>
	<keyword>Oncology</keyword>
	<keyword>Cancer</keyword>
	<keyword>Solid Tumors</keyword>
</DOC>